Procter & Gamble Hygiene & Health Care Executes ₹100.06 Crore Block Trade on NSE Aug 08, 2025
More news about P&G Hygiene and Health Care
30Jul 25
Procter & Gamble Hygiene & Health Care Reports Robust Q1 Performance with EBITDA Surging 122%
P&G Hygiene and Health Care Ltd. delivered impressive Q1 results, showcasing significant profitability improvements despite modest revenue growth. Revenue increased by 1.08% to ₹9.40 billion, while EBITDA surged by 122% to ₹2.66 billion. The EBITDA margin expanded by 15.71 percentage points to 28.41%. Net profit saw a substantial increase of 136.70% to ₹1.92 billion. These results indicate successful cost management and enhanced operational efficiency, positioning the company strongly in the hygiene and health care sector.
Procter & Gamble (P&G) has revealed plans for a significant strategic restructuring of its product portfolio, including the divestiture of multiple categories and brands. This move aims to streamline operations and potentially focus on core, high-performing product lines. While specific details about the categories and brands to be divested are not yet disclosed, the restructuring could lead to portfolio optimization, resource reallocation, and market repositioning for P&G. This decision aligns with broader industry trends of reevaluating product portfolios in response to evolving market dynamics and consumer preferences.
05Jun 25
Procter & Gamble Announces Global Workforce Reduction of 7,000 Jobs
Procter & Gamble (P&G) has revealed plans to eliminate 7,000 non-manufacturing jobs worldwide, representing about 15% of its non-manufacturing workforce. This restructuring initiative will be implemented over the next two years as part of a broader strategy to enhance operational efficiency. The impact on P&G's Indian subsidiary, Procter & Gamble Hygiene and Health Care Limited, remains unclear. The company has not provided specific details on how the restructuring will be distributed across different regions or subsidiaries.
27May 25
Procter & Gamble Hygiene and Health Care Reports Slight Profit Increase in Q4, Revenue Dips
Procter & Gamble Hygiene & Health Care's Q4 results show a 1.1% increase in net profit to ₹156.10 crore, despite a 1.05% decrease in revenue to ₹991.63 crore. Total expenses rose by 11.24% to ₹791.10 crore. EBITDA declined by 18.29% to ₹2.10 billion, with the EBITDA margin dropping to 21.21%. The company recommended a dividend of ₹65 per equity share.
26Mar 25
Procter & Gamble Hygiene and Health Care to Review Q4 Results and Consider Dividend on May 27
Procter & Gamble Hygiene and Health Care Limited has announced a board meeting on May 27, 2025, to review Q4 and FY 2025 financial results and consider dividend recommendation. The company's trading window will be closed from April 1, 2025, until 48 hours after the results publication to prevent insider trading.